The expression of certain blood-brain barrier (BBB) properties in CNS
endothelial cells appear to be dependent on astroglial interactions in
vitro. However, evidence for direct astroglial support of BBB functio
n in vivo is controversial. To determine if perivascular astroglial da
mage or loss would compromise BBB function in situ, localized astrogli
al degeneration was produced in adult rat spinal cords by systemic inj
ections of the anti-metabolite 6-aminonicotinamide (6-AN). Between 1 a
nd 5 days after 6-AN administration, microvessels in the lumbar spinal
cord (blood-spinal cord barrier) were examined for the expression of
several BBB markers and for leakage of endogenous and exogenous protei
ns by means of immunocytochemical and histochemical procedures. Glial
cells throughout the gray matter were swollen after 24 h, and by 5 day
s post-injection perivascular astroglia in laminae VI-VIII appeared co
mpletely degenerated. Microvessels were undamaged and continued to exp
ress BBB markers such as GLUT-I, gamma-glutamyltranspeptidase, and end
othelial barrier antigen in this region in a manner comparable to cont
rol animals. These results suggest that differentiated, BBB-competent
microvascular endothelia in situ may not depend on continuous astrogli
al support to maintain these particular BBB characteristics. However,
the BBB to protein appeared to be compromised; the gray matter was imm
unoreactive for serum albumin and some areas were permeable to intrava
scularly injected horseradish peroxidase (HRP). No increase in microva
scular transport vesicles was apparent, and no open, tracer-containing
interendothelial junctions were detected using standard ultrastructur
al methods. Some venous structures were surrounded by hemorrhages and
HRP reaction product. Thus, astrocytic injury may alter venous, and po
ssibly microvascular, permeability to macromolecules. (C) 1994 Wiley-L
iss, Inc.